Brett Mahon
Tempus Labs (United States)(US)
Publications by Year
Research Areas
Cancer Genomics and Diagnostics, Lung Cancer Diagnosis and Treatment, Gastric Cancer Management and Outcomes, Lung Cancer Treatments and Mutations, Colorectal Cancer Screening and Detection
Most-Cited Works
- → Clinical validation of the tempus xT next-generation targeted oncology sequencing assay(2019)228 cited
- → Multi-Field-of-View Deep Learning Model Predicts Nonsmall Cell Lung Cancer Programmed Death-Ligand 1 Status from Whole-Slide Hematoxylin and Eosin Images(2019)124 cited
- → Plasma lipidomics profiling identified lipid biomarkers in distinguishing early-stage breast cancer from benign lesions(2016)117 cited
- Primary cutaneous and systemic anaplastic large cell lymphoma: clinicopathologic aspects and therapeutic options.(2010)
- → Biomarkers of the Insulin-Like Growth Factor Pathway Predict Progression and Outcome in Lung Cancer(2011)57 cited
- → Development and Validation of a Plasma Biomarker Panel for Discerning Clinical Significance of Indeterminate Pulmonary Nodules(2012)49 cited
- → Presence of small sessile serrated polyps increases rate of advanced neoplasia upon surveillance compared with isolated low-risk tubular adenomas(2016)40 cited
- → Myocardial hydrophilic polymer emboli following cardiac catheterization: a case report and literature review(2014)27 cited
- → Breast implant-associated anaplastic large-cell lymphoma and the role of brentuximab vedotin (SGN-35) therapy: A case report and review of the literature(2017)22 cited
- → Cytologic features of meningiomas on crush preparations: A review(2008)21 cited